Transcatheter atrial septal defects and patent foramen ovale closure: Medicare utilization and reimbursements
Medicare utilization of transcatheter ASD/PFO closure therapies has grown significantly in procedural volume from 2013 to 2022. However, this has been accompanied by a decrease in per-case reimbursements.
Authors
- Marina Byer (ORCID: https://orcid.org/0000-0002-2755-4690)
- Rohan Deo
- Pengyang Li (ORCID: https://orcid.org/0000-0003-2272-9102)
- Rhea Sancassani (ORCID: https://orcid.org/0000-0002-9624-3132)
- Vidit Majmundar (ORCID: https://orcid.org/0000-0002-4572-8957)
- Ajay Mishra (ORCID: https://orcid.org/0000-0002-4422-3981)
Institutions
- Saint Vincent Hospital (US)
Publication Details
- Journal
- World Journal of Methodology
- Published
- 2025-08-03
- DOI
- https://doi.org/10.5662/wjm.v15.i4.103146
- Primary Topic
- Cardiovascular and Diving-Related Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00